Abbvie Inc
NYSE:ABBV
Abbvie Inc
Total Assets
Abbvie Inc
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Total Assets
$134.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Assets
$62.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Assets
$97.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Assets
$22.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
29%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Assets
$33.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
23%
|
CAGR 10-Years
27%
|
|
Seagen Inc
NASDAQ:SGEN
|
Total Assets
$3.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
See Also
What is Abbvie Inc's Total Assets?
Total Assets
134.7B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Assets amounts to 134.7B USD.
What is Abbvie Inc's Total Assets growth rate?
Total Assets CAGR 10Y
17%
Over the last year, the Total Assets growth was -3%. The average annual Total Assets growth rates for Abbvie Inc have been -4% over the past three years , 18% over the past five years , and 17% over the past ten years .